Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses.
about
Refocusing of B-cell responses following a single amino acid substitution in an antigenMF59™ as a vaccine adjuvant: a review of safety and immunogenicity.Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.Herpes simplex virus type 2 vaccines: new ground for optimism?Characterization of human immunodeficiency virus Gag-specific gamma interferon-expressing cells following protective mucosal immunization with alphavirus replicon particles.Oral administration of influenza vaccine in combination with the adjuvants LT-K63 and LT-R72 induces potent immune responses comparable to or stronger than traditional intramuscular immunizationIntranasal immunization of mice with influenza vaccine in combination with the adjuvant LT-R72 induces potent mucosal and serum immunity which is stronger than that with traditional intramuscular immunization.Intranasal immunization with Toxoplasma gondii SAG1 induces protective cells into both NALT and GALT compartmentsTrachea, lung, and tracheobronchial lymph nodes are the major sites where antigen-presenting cells are detected after nasal vaccination of mice with human papillomavirus type 16 virus-like particles.ISCOM-based vaccines: the second decade.The role of adjuvants in the development of mucosal vaccines.Intranasal delivery of vaccines against HIV.Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.Bioadhesive delivery systems for mucosal vaccine delivery.Intranasal immunization against influenza virus using polymeric particles.Large-scale comparison of experimental adjuvants with herpes simplex virus vaccine reveals a correlation of protection with IgG2a and IgG2b responses.Enhanced mucosal and systemic immune responses to Helicobacter pylori antigens through mucosal priming followed by systemic boosting immunizations.
P2860
Q28367028-448817EE-9B52-4D02-A67D-2612EF15B19FQ30394545-528E4411-4C92-40BB-B737-0CB5A54C2B74Q33591055-5B79F662-2109-41C2-B50B-C65DEDF1210CQ33711912-66332A91-5B35-4F4D-9C5F-FA5AADBB8EC2Q33788861-D0992282-7567-4D4D-9BA3-4CD6FDBB3B0BQ33999182-E2852E62-0B6A-4ADC-9B86-20B58F391417Q34001562-FA53C823-B3AF-438E-A050-FC168A15A1CFQ34003394-1B8DC1E9-A82C-4330-B995-510A53F47D9BQ34353473-74FD6846-54B3-48BF-AAAF-16D9D6BE5174Q36062124-2BEDC948-266A-4DA3-985D-3C82C5F56372Q36194084-8562BC34-BED4-4EFC-936B-4BD28A54CA92Q36409054-20C135E6-68B1-4014-B021-13D5C9F83847Q37531713-433915CF-A42B-4CC9-B9D2-62C26B84EDF1Q37805519-2A7ABBE4-DF36-4D16-B11A-5E8DFFD62116Q43970626-5929BE15-BAB0-45B8-8372-8821BA01B5F1Q45731074-30322B99-AAD5-4237-9BE3-93C7FB9D43AFQ47663900-66CE472E-74E2-42C6-BC7B-D60D7B758460
P2860
Intranasal immunization of mice with herpes simplex virus type 2 recombinant gD2: the effect of adjuvants on mucosal and serum antibody responses.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Intranasal immunization of mic ...... and serum antibody responses.
@en
Intranasal immunization of mic ...... and serum antibody responses.
@nl
type
label
Intranasal immunization of mic ...... and serum antibody responses.
@en
Intranasal immunization of mic ...... and serum antibody responses.
@nl
prefLabel
Intranasal immunization of mic ...... and serum antibody responses.
@en
Intranasal immunization of mic ...... and serum antibody responses.
@nl
P2093
P2860
P1433
P1476
Intranasal immunization of mic ...... and serum antibody responses.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2567.1998.00441.X
P577
1998-04-01T00:00:00Z